Mendelspod Podcast

Sequenom Patent Loss a Threat to Personalized Medicine, Says Kevin Noonan

Informações:

Synopsis

It’s a non-decision with big implications. On Monday, the Supreme Court turned down an appeal by Sequenom in their patent case with Ariosa. The rebuff by the highest court kills Sequenom’s prenatal screening test patent for good.